Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Immunity 31:53950
For PT-141 to be commercially available on a global scale, cooperation from countries all over the world regarding research and integration will be required
A major challenge in neurodegeneration research is to elucidate how the reactive astrocytes are regulated and how these phenotypic shifts contribute to disease progression
Therapeutic modulation of the autophagy-mitophagy axis in autoimmune diseases Autophagy inhibition to restrain inflammatory signaling CQ and HCQ represent clinically established autophagy inhibitors with broad immunomodulatory actions
On the UK market since 2013
US$ 26.72
US$ 26.57
US$ 24.69
